Si-544
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Si-544, covering 2025-07-03 to 2025-07-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis [Phase 1]